Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)

NCT00094120 is registered in ClinicalTrials.gov with Genaera Corporation as lead sponsor.

NCT NCT00094120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00094120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
Lead sponsor
Genaera Corporation
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2004
Completion date
February 28, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration